Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity
Sheldrake, Helen M., Travica, Sandra, Johansson, Inger, Loadman, Paul M., Sutherland, Mark, Elsalem, Lina, Illingworth, Nicola, Cresswell, Alexander J., Reuillon, Tristan, Shnyder, Steven D., MkrtchiaVolume:
56
Langue:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/jm4000209
Date:
August, 2013
Fichier:
PDF, 695 KB
english, 2013
File converter
Plus de résultats de recherche
More benefits 
